Synchrony Financial (SYF) Research & Development (2013 - 2026)

Synchrony Financial (SYF) has reported Research & Development for 14 consecutive years, with $248.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 15.35% year-over-year to $248.0 million; the trailing twelve-month figure through Jun 2026 stood at $975.0 million (up 15.52% YoY), and the FY2025 full-year result was $899.0 million, up 11.96% from the prior year.
• Research & Development retreated to $248.0 million in Q2 2026 per SYF's latest filing, from $262.0 million in the prior quarter.
• Across five years, Research & Development topped out at $262.0 million in Q1 2026 and bottomed at $145.0 million in Q1 2022.
• Historically, Research & Development has averaged $197.1 million across 5 years, with a median of $196.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Research & Development advanced 3.86% in 2025, then grew 19.63% in 2026.
• Over 5 years, Research & Development stood at $165.0 million in 2022, then climbed by 15.15% to $190.0 million in 2023, then increased by 8.95% to $207.0 million in 2024, then rose by 15.46% to $239.0 million in 2025, then gained by 3.77% to $248.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $248.0 million, $262.0 million, and $239.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.